Revised August 2018
Resources for clinicians to help them treat opioid-dependent pregnant women, mothers, & infants.
Practice Guidance
- Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants (SAMHSA)
- Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy (WHO)
- Opioid Use and Opioid Use Disorder in Pregnancy: ACOG Committee Opinion (ACOG/ASAM)
- National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use (See Part 8: SPECIAL POPULATIONS: PREGNANT WOMEN) (ASAM)
- A Public Health Response to Opioid Use in Pregnancy: Policy Statement (AAP)
- Neonatal Drug Withdrawal: Policy Statement (AAP)
- Guidelines for Breastfeeding and Substance Use or Substance Use Disorder (ABM)
- Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction (see chapter 5 – special populations) (SAMHSA, CSAT)
Research & News
- Treating Women Who are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of their Infants and Children: Literature Review to Support National Guidance (Addiction Medicine, 2017)
- Study suggests safety of breastfeeding by new mothers being treated with buprenorphine (NIDA, JHL)
- Opioids and Women Final Report Released (OWH)
- NIDA editorial urges safer opioid prescribing practices for pregnant women (NIDA)
- Women who inject drugs may be greater risk HCV (NIDA)
- NICHD-Supported Opioids Research (NICHD)
Further Education
- Neonatal Abstinence Syndrome and Clinical Decisions: Interview with Hendree Jones (NIDA)
- Treating Opioid Use During Pregnancy (NIDA)
- A collaborative approach to the treatment of pregnant women with OUD (SAMHSA)
- Webinar Series on Opioid Use Disorders and Treatment – "Webinar series on medication-assisted treatment for families affected by substance use disorders, opioid use in pregnancy and treatment for Neonatal Abstinence Syndrome." (NCSACW, SAMHSA)
